EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Activation of Endothelial TRPV4 Exacerbates Myocardial Ischemia-Reperfusion Injury via Vascular Integrity Impairment

Miaomiao Zhang, Yan Zou, Hongyun Ruan, Yingyu Chen, Zixuan Li, Yan Liu, Yimei Du, Bing Han

Canadian Journal of Cardiology · 2025

DOI: 10.1016/j.cjca.2025.11.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Cardiology, 2025. Verfasst von Miaomiao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: TRPV Cation Channels, Myocardial Reperfusion Injury, Endothelium, Vascular, Endothelial Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Activation of transient receptor potential vanilloid 4 (TRPV4) exacerbates myocardial ischemia-reperfusion (IR) injury and is highly expressed in vascular endothelial cells. The role of TRPV4 in cardiac endothelial cells (CECs) during IR remains unclear. We hypothesized that endothelial TRPV4 contributes to postischemic vascular hyperpermeability and myocardial injury by modulating barrier function and apoptosis. METHODS: Myocardial IR was induced in C57BL/6 wild type, global TRPV4 knockout, and tamoxifen-inducible endothelial TRPV4 knockout cells, and tamoxifen-treated controls. Primary cultured CECs (passage 3) were subjected to hypoxia-reoxygenation and treated with the TRPV4 antagonist GSK2193874 or agonist GSK101790A. RESULTS: Mice lacking TRPV4 mice exhibited smaller infarcts, preserved endothelial integrity, decreased vascular permeability, upregulated vascular endothelial-cadherin, claudin-5, and occludin, and reduced inflammation. GSK2193874 pretreatment reproduced these protective effects, whereas TRPV4 activation worsened injury. Endothelial-specific TRPV4 knockout provided similar protection. In CECs, TRPV4 inhibition attenuated hypoxia-reoxygenation-induced permeability increases and junctional protein loss, whereas TRPV4 agonist alone increased permeability and reduced vascular endothelial-cadherin, claudin-5, and occludin. Mechanistically, TRPV4 activation increased CEC permeability via the Ca2+/protein kinase C (PKC)/Ras homolog family gene member A (RhoA)/myosin light chain (MLC) pathway and promoted apoptosis through mitogen-activated protein kinase-protein kinase B signalling. CONCLUSIONS: Activation of endothelial TRPV4 CECs exacerbates post-IR vascular hyperpermeability and myocardial injury by impairing barrier integrity and promoting apoptosis. Targeting endothelial TRPV4 might represent a promising therapeutic strategy to mitigate myocardial IR injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TRPV Cation ChannelsMyocardial Reperfusion InjuryEndothelium, VascularEndothelial CellsAnimalsMiceMice, KnockoutMice, Inbred C57BLApoptosisDisease Models, AnimalCapillary PermeabilityCells, CulturedMaleLeucinePiperidinesQuinolinesSulfonamides

Stichwörter der Autor:innen

endothelial transient receptor potential vanilloid 4myocardial ischemia-reperfusionvascular permeability

Substanzen

TRPV Cation ChannelsTrpv4 protein, mouseGSK2193874N-(1-((4-(2-(((2,4-dichlorophenyl)sulfonyl)amino)-3-hydroxypropanoyl)-1-piperazinyl)carbonyl)-3-methylbutyl)-1-benzothi…LeucinePiperidinesQuinolinesSulfonamides

Autor:innen und Institutionen

  • Department of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, China.
  • Xuzhou Clinical School of Xuzhou Medical University, Division of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.
  • Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei Province, China. Electronic address: yimeidu@mail.hust.edu.cn.
  • Department of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China; Xuzhou Clinical School of Xuzhou Medical University, Division of Cardiology, Xuzhou Central Hospital, Xuzhou, Jiangsu Province, China.…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhang, M., Zou, Y., Ruan, H., Chen, Y., Li, Z., Liu, Y., Du, Y., & Han, B. (2025). Activation of Endothelial TRPV4 Exacerbates Myocardial Ischemia-Reperfusion Injury via Vascular Integrity Impairment. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2025.11.007

Vancouver

Zhang M, Zou Y, Ruan H, Chen Y, Li Z, Liu Y, et al. Activation of Endothelial TRPV4 Exacerbates Myocardial Ischemia-Reperfusion Injury via Vascular Integrity Impairment. Canadian Journal of Cardiology. 2025. doi:10.1016/j.cjca.2025.11.007

BibTeX
@article{Zhang2025,
  author = {Zhang, Miaomiao and Zou, Yan and Ruan, Hongyun and Chen, Yingyu and Li, Zixuan and Liu, Yan and Du, Yimei and Han, Bing},
  title = {Activation of Endothelial TRPV4 Exacerbates Myocardial Ischemia-Reperfusion Injury via Vascular Integrity Impairment},
  journal = {Canadian Journal of Cardiology},
  year = {2025},
  doi = {10.1016/j.cjca.2025.11.007}
}
Kostenlos starten →